Metraipolis › archive › dc_ff4e86ebfdb8

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials — Europe PMC PMID:41050680

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41050680
DOI: 10.3389/fimmu.2025.1654343
License (as archived): solo-consultazione
Archived: 2026-11-09T20:59:13.773Z
SHA-256 of the archived text: d0d7470e94f03746f4a58514eddb4d69a7c0491bd5de4f698f6ae8bdf2085ae5
Stable URL of this page: https://metraipolis.com/documento/dc_ff4e86ebfdb8

How to cite

Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials — Europe PMC PMID:41050680 — Europe PMC (en), https://europepmc.org/article/MED/41050680 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ff4e86ebfdb8 (Metraipolis archive dc_ff4e86ebfdb8, sha256 d0d7470e94f03746f4a58514eddb4d69a7c0491bd5de4f698f6ae8bdf2085ae5)

BibTeX

@misc{dcff4e86ebfdb8,
  title = {Efficacy and safety of IL-17, IL-12/23, and IL-23 inhibitors for psoriatic arthritis: a network meta-analysis of randomized controlled trials — Europe PMC PMID:41050680},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41050680},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ff4e86ebfdb8; sha256 d0d7470e94f03746f4a58514eddb4d69a7c0491bd5de4f698f6ae8bdf2085ae5},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41050680. Agents can read the archived copy with the MCP tool read_document.